Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis

References

• Whiteside TL. Immune responses to malignancies. J Allergy Clin Immunol 2003; 111: S677–S686
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Immunobiology of head and neck cancer. Cancer Metastasis Rev 2005; 24: 95–105
   PubMed Web of Science ®Google Scholar
• McKechnie A, Robins RA, Eremin O. Immunological aspects of head and neck cancer: biology, pathophysiology and therapeutic mechanisms. Surgeon 2004; 2: 187–207
   PubMed Web of Science ®Google Scholar
• Bauernhofer T, Kuss I, Henderson B, Baum AS, Whiteside TL. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur J Immunol 2003; 33: 119–24
   PubMed Web of Science ®Google Scholar
• Kross KW, Heimdal JH, Olsnes C, Olofsson J, Aarstad HJ. Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density. Acta Otolaryngol (Stockh) 2005; 125: 1097–104
   PubMed Web of Science ®Google Scholar
• Olsnes C, Heimdal JH, Kross KW, Olofsson J, Aarstad HJ. Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors. Eur Arch Otorhinolaryngol 2005; 262: 953–60
   PubMed Web of Science ®Google Scholar
• Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 2004; 10: 3755–62
   PubMed Web of Science ®Google Scholar
• Heimdal JH, Aarstad HJ, Olofsson J. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma. Laryngoscope 2000; 110: 402–7
   PubMed Web of Science ®Google Scholar
• Caruso A, Licenziati S, Corulli M, Canaris AD, De-Francesco MA, Fiorentini S, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 1997; 27: 71–6
   PubMedGoogle Scholar
• Tartour E, Mosseri V, Jouffroy T, Deneux L, Jaulerry C, Brunin F, et al. Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer. Lancet 2001; 357: 1263–4
   PubMed Web of Science ®Google Scholar
• Reddy M, Eirikis E, Davis C, Davis HM, Prabhakar U. Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function. J Immunol Methods 2004; 293: 127–42
   PubMed Web of Science ®Google Scholar
• Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003; 21: 273–6
   PubMed Web of Science ®Google Scholar
• Meloni F, Vitulo P, Bianco AM, Paschetto E, Morosini M, Cascina A, et al. Regulatory CD4 + CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 2004; 77: 762–6
   PubMed Web of Science ®Google Scholar
• Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 2002; 169: 3400–6
   PubMed Web of Science ®Google Scholar
• Jones GW, Browman G, Goodyear M, Marcellus D, Hodson DI. Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer. Head Neck 1993; 15: 497–503
   PubMed Web of Science ®Google Scholar
• Gonzalez FM, Vargas JA, Gea-Banacloche JC, Garcia JR, Berrocal E, Gorriz C, et al. Functional and phenotypic analysis of T-lymphocytes in laryngeal carcinoma. Acta Otolaryngol (Stockh) 1994; 114: 663–8
   PubMed Web of Science ®Google Scholar
• Kim JW, Tsukishiro T, Johnson JT, Whiteside TL. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2004; 10: 5101–10
   PubMed Web of Science ®Google Scholar
• Schaefer C, Kim GG, Albers A, Hoermann K, Myers EN, Whiteside TL. Characteristics of CD4 + CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br J Cancer 2005; 92: 913–20
   PubMed Web of Science ®Google Scholar
• Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL. Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Clin Cancer Res 1999; 56: 1263–73
   Google Scholar
• Pavlicek J, Sopko B, Ettrich R, Kopecky V, Jr, Baumruk V, Man P, et al. Molecular characterization of binding of calcium and carbohydrates by an early activation antigen of lymphocytes CD69. Biochemistry 2003; 42: 9295–306
   PubMed Web of Science ®Google Scholar
• Marzio R, Mauel J, Betz Corradin S. CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol 1999; 21: 565–82
   PubMed Web of Science ®Google Scholar
• Posselt AM, Vincenti F, Bedolli M, Lantz M, Roberts JP, Hirose R. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Transplantation 2003; 76: 190–5
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?. Cancer Immunol Immunother 2004; 53: 865–78
   PubMed Web of Science ®Google Scholar
• Reichert TE, Day R, Wagner EM, Whiteside TL. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma. Cancer Res 1998; 58: 5344–7
   PubMed Web of Science ®Google Scholar
• Nakamura H, Idiris A, Kato Y, Kato H. An increase in the percentage of HLA-DR-positive peripheral leukocytes predicts a poor prognosis in patients with squamous cell carcinoma of the lung. Oncol Rep 2004; 11: 673–6
   PubMed Web of Science ®Google Scholar
• Nakamura H, Saji H, Aute I, Kawasaki N, Hosaka M, Ogata A, et al. Peripheral leukocytes with HLA-DR + /CD8- phenotype are associated with prognosis in patients with lung cancer. Anticancer Res 2003; 23: 4149–52
   PubMed Web of Science ®Google Scholar
• Nakamura H, Saji H, Ogata A, Hosaka M, Hagiwara M, Kawasaki N, et al. Immunologic parameters as significant prognostic factors in lung cancer. Lung Cancer 2002; 37: 161–9
   PubMed Web of Science ®Google Scholar
• Niitsu N, Iijima K, Chizuka A. A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma. Eur J Haematol 2001; 66: 24–30
   PubMed Web of Science ®Google Scholar
• Vuoristo MS, Laine S, Huhtala H, Parvinen LM, Hahka-Kemppinen M, Korpela M, et al. Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma. Eur J Cancer 2001; 37: 1629–34
   PubMed Web of Science ®Google Scholar
• Van Belle SJ, Cocquyt V. Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol Hematol 2003; 47: 1–11
   PubMed Web of Science ®Google Scholar
• Hoffmann TK, Bier H, Whiteside TL. Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 2004; 53: 1055–67
   PubMed Web of Science ®Google Scholar